OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Precision diagnostics in lymphomas – Recent developments and future directions
Larry Mansouri, Birna Þorvaldsdóttir, Stamatia Laidou, et al.
Seminars in Cancer Biology (2021) Vol. 84, pp. 170-183
Open Access | Times Cited: 14
Larry Mansouri, Birna Þorvaldsdóttir, Stamatia Laidou, et al.
Seminars in Cancer Biology (2021) Vol. 84, pp. 170-183
Open Access | Times Cited: 14
Showing 14 citing articles:
Genomic profiling for clinical decision making in lymphoid neoplasms
Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2193-2227
Open Access | Times Cited: 109
Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2193-2227
Open Access | Times Cited: 109
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
Silvia Bonfiglio, Lesley‐Ann Sutton, Viktor Ljungström, et al.
Blood Advances (2023) Vol. 7, Iss. 12, pp. 2794-2806
Open Access | Times Cited: 44
Silvia Bonfiglio, Lesley‐Ann Sutton, Viktor Ljungström, et al.
Blood Advances (2023) Vol. 7, Iss. 12, pp. 2794-2806
Open Access | Times Cited: 44
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Larry Mansouri, Birna Þorvaldsdóttir, Lesley‐Ann Sutton, et al.
Leukemia (2022) Vol. 37, Iss. 2, pp. 339-347
Open Access | Times Cited: 39
Larry Mansouri, Birna Þorvaldsdóttir, Lesley‐Ann Sutton, et al.
Leukemia (2022) Vol. 37, Iss. 2, pp. 339-347
Open Access | Times Cited: 39
Novel precision medicine approaches and treatment strategies in hematological malignancies
Richard Rosenquist, Elsa Bernard, Tom Erkers, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 413-436
Open Access | Times Cited: 19
Richard Rosenquist, Elsa Bernard, Tom Erkers, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 413-436
Open Access | Times Cited: 19
Molecular classification and therapeutics in diffuse large B-cell lymphoma
Gaelen Shimkus, T. NONAKA
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8
Gaelen Shimkus, T. NONAKA
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8
Multisite clinical cross-validation and variant interpretation of a next generation sequencing panel for lymphoid cancer prognostication
Peter Sabatini, Joshua Bridgers, Shujun Huang, et al.
Journal of Clinical Pathology (2024), pp. jcp-209262
Open Access | Times Cited: 2
Peter Sabatini, Joshua Bridgers, Shujun Huang, et al.
Journal of Clinical Pathology (2024), pp. jcp-209262
Open Access | Times Cited: 2
Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study
Z. Haider, Tove Wästerlid, Linn Deleskog Spångberg, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Z. Haider, Tove Wästerlid, Linn Deleskog Spångberg, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
The future of lymphoma diagnosis, prognosis, and treatment monitoring in countries with limited access to pathology services
Clara Chamba, William Frank Mawalla
Seminars in Hematology (2023) Vol. 60, Iss. 4, pp. 215-219
Open Access | Times Cited: 4
Clara Chamba, William Frank Mawalla
Seminars in Hematology (2023) Vol. 60, Iss. 4, pp. 215-219
Open Access | Times Cited: 4
Data-driven support to decision-making in molecular tumour boards for lymphoma: A design science approach
Núria Rodríguez Ruiz, Sulaf Abd Own, Karin E. Smedby, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Núria Rodríguez Ruiz, Sulaf Abd Own, Karin E. Smedby, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Critical Role of Aquaporins in Cancer: Focus on Hematological Malignancies
Alessandro Allegra, Nicola Cicero, Giuseppe Mirabile, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4182-4182
Open Access | Times Cited: 6
Alessandro Allegra, Nicola Cicero, Giuseppe Mirabile, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4182-4182
Open Access | Times Cited: 6
The BioLymph study – implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results
Karin E. Smedby, Tove Wästerlid, Emma Tham, et al.
Acta Oncologica (2023) Vol. 62, Iss. 6, pp. 560-564
Open Access | Times Cited: 3
Karin E. Smedby, Tove Wästerlid, Emma Tham, et al.
Acta Oncologica (2023) Vol. 62, Iss. 6, pp. 560-564
Open Access | Times Cited: 3
Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia
Blaž Oder, Anastasia Chatzidimitriou, Anton W. Langerak, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Blaž Oder, Anastasia Chatzidimitriou, Anton W. Langerak, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Smart variant filtering - A blueprint solution for massively parallel sequencing-based variant analysis
Orlinda Brahimllari, Sandra Eloranta, Patrik Georgii‐Hemming, et al.
Health Informatics Journal (2024) Vol. 30, Iss. 4
Closed Access
Orlinda Brahimllari, Sandra Eloranta, Patrik Georgii‐Hemming, et al.
Health Informatics Journal (2024) Vol. 30, Iss. 4
Closed Access
Molekulare Klassifizierung und Therapien des diffusen großzelligen B-Zell-Lymphoms
Gaelen Shimkus, T. NONAKA
Kompass Onkologie (2023) Vol. 10, Iss. 2, pp. 59-76
Closed Access
Gaelen Shimkus, T. NONAKA
Kompass Onkologie (2023) Vol. 10, Iss. 2, pp. 59-76
Closed Access
